Quinolines and azaquinolines as inhibitors of cd38
CR20260120APending Publication Date: 2026-06-12BOEHRINGER INGELHEIM INT GMBH
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CR20260120P0
- Authority / Receiving Office
- CR · CR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-01-28
- Filing Date
- 2022-01-28
- Publication Date
- 2026-06-12
Abstract
Compounds that are CD38 inhibitors and are useful for cancer treatment
Need to check novelty before this filing date? Find Prior Art